MAUDE Adverse Event Report: ACCRIVA DIAGNOSTICS HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM; SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES

Model Number ELITE

Device Problem High Test Results (2457)

Patient Problems No Known Impact Or Consequence To Patient (2692); Missing Value Reason (3192)

Event Date 06/21/2018

Event Type  malfunction  

Manufacturer Narrative

This mdr references accriva diagnostics' complaint number (b)(4) for the hemochron signature elite, serial number (b)(4), the parent case.This mdr also captures a child complaint (b)(4)for the hemochron jr act-lr (low-range) reagent cuvette used.Method codes: analysis of production records.No history of service or repairs.Results code: no findings available.Conclusion code: conclusion not yet available.Accriva diagnostics has requested all data required for form 3500a.This is the initial 30-day report that precedes the instrument evaluation.Mdr follow-up #1 will be submitted if the device is returned to the manufacturer for evaluation.

Event Description

Healthcare professional reported that a hemochron signature elite and low-range act system reported higher than expected act results during a pci procedure.The patient was receiving intravenous heparin with a target act of >250 seconds.One blood sample generated an act result that was >400 seconds, which was a higher than expected result.Another blood sample drawn 12 minutes was assayed on a second hemochron signature elite with the same lot of reagent cuvettes, which generated an act result of 180 seconds, which was an expected result.An intravenous bolus dose of heparin was administered and the procedure was successfully completed.The hemochron signature elite and low-range act system passed electronic and liquid qc before the procedure.No bleeding or medical complications were reported.

Manufacturer Narrative

Mdr 2250033-2018-00016 follow-up #1 provides the results of the instrument evaluation for the hemochron signature elite instrument, serial number (b)(4) named in accriva diagnostics' complaint number (b)(4).Method code: 10 actual device was evaluated.Results code: 213 no failure detected.Whole blood liquid qc was assayed with retains of the same cuvette lot used in the procedure.Results were found to be within specifications and close to the mean.Electronic qc passed as well.Conclusion code: 67 unable to confirm complaint.

Event Description

Follow-up #1.

• Brand Name: HEMOCHRON SIGNATURE ELITE MICROCOAGULATION SYSTEM
• Type of Device: SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
• Manufacturer (Section D): ACCRIVA DIAGNOSTICS; 6260 sequence drive; san diego CA 92121
• MDR Report Key: 7701010
• MDR Text Key: 114676750
• Report Number: 2250033-2018-00016
• Device Sequence Number: 1
• Product Code: JPA
• UDI-Device Identifier: 10711234510018
• UDI-Public: 10711234510018
• Combination Product (y/n): N
• PMA/PMN Number: K050016
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: health professional
• Type of Report: Initial,Followup
• Report Date: 08/09/2018

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 07/18/2018
• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Model Number: ELITE
• Device Catalogue Number: ELITE
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 07/24/2018
• Date Manufacturer Received: 07/24/2018
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Patient Age: 89 YR
• Patient Weight: 75